US5049221055
© PR Newswire
15.01.2026
LH
LISTED
NYSE
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026
News Preview
BURLINGTON, N.C., Jan. 15, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on Tuesday, February 17, 2026. The company will host a conference call and webcast beginning at 9 a.m. ET th...
Themefolio
Profiler
Peergroup
© PR Newswire
14.01.2026
LH
LISTED
NYSE
Labcorp Declares Quarterly Dividend
News Preview
BURLINGTON, N.C., Jan. 14, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 12, 2026, to stockholders of record as of the close...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
LH
LISTED
NYSE
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
News Preview
Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imagingLabcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancerBURLINGTON, N.C., Jan. 13, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and c...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
08.01.2026
LH
LISTED
NYSE
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
News Preview
Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, FDA-authorized PCR test for sexually transmitted infections (STIs) available to consumers, enabling immediate access to Visby’s integrated "Test-to-Treat" ecosystem. The palm-sized device delivers confi...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
08.01.2026
LH
LISTED
NYSE
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
News Preview
TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing business of Labcorp (NYSE: LH), a leading provider of innovative and comprehensive laboratory services. Th...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
LH
LISTED
NYSE
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
BURLINGTON, N.C., Dec. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, at 4:30 p.m. PT....
Themefolio
Profiler
Peergroup
© PR Newswire
24.11.2025
LH
LISTED
NYSE
Labcorp Appoints Victor Bulto to Board of Directors
News Preview
Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategyBURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of Victor Bulto, a seasoned pharmaceutical ex...
Themefolio
Profiler
Peergroup
© PR Newswire
19.11.2025
LH
LISTED
NYSE
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
News Preview
Studies demonstrate Labcorp Plasma Detect MRD Technology can inform treatment strategies and advance cancer research
BURLINGTON, N.C., Nov. 19, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today an...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
LH
LISTED
NYSE
Labcorp Announces 2025 Third Quarter Results
News Preview
Updates Full-Year Guidance
Financial results from Operations for third quarter 2025 versus third quarter 2024:Revenue: $3.56 billion versus $3.28 billionDiluted EPS: $3.12 versus $2.00Adjusted EPS: $4.18 versus $3.50
Updated Full-Year Enterpris...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
LH
LISTED
NYSE
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings
News Preview
Labcorp plans to make Roche's Elecsys® pTau181 test available nationwide by early 2026
BURLINGTON, N.C., Oct. 23, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elec...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
LH
LISTED
NYSE
Labcorp Declares Quarterly Dividend
News Preview
BURLINGTON, N.C., Oct. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 11, 2025, to s...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
LH
LISTED
NYSE
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
News Preview
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services
BURLINGTON, N.C., Sept. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and com...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
25.09.2025
LH
LISTED
NYSE
Labcorp to Announce Third Quarter Financial Results on October 28, 2025
News Preview
BURLINGTON, N.C., Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET th...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
LH
LISTED
NYSE
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
News Preview
BURLINGTON, N.C. and MIAMI, Sept. 15, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp's acquisition of select assets of BioReference Health, a wholl...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
LH
LISTED
NYSE
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
BURLINGTON, N.C., Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sept. 9, at 7:45 am ET....
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
LH
LISTED
NYSE
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
News Preview
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp
BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IV...
Themefolio
Profiler
Peergroup
© PR Newswire
30.07.2025
LH
LISTED
NYSE
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
News Preview
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search
Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com
BURLINGTON, N.C., July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive l...
Themefolio
Profiler
Peergroup
© PR Newswire
29.07.2025
LH
LISTED
NYSE
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
News Preview
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU
BURLINGTON, N.C., July 29, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today PGDx elio™ tissue complete has been CE-marked u...
Themefolio
Profiler
Peergroup
© PR Newswire
24.07.2025
LH
LISTED
NYSE
Labcorp Announces 2025 Second Quarter Results
News Preview
Raises Full-Year Guidance
Financial results from Operations for second quarter 2025 versus second quarter 2024:Revenue: $3.53 billion versus $3.22 billionDiluted EPS: $2.84 versus $2.43Adjusted EPS: $4.35 versus $3.94Raised Enterprise Revenue, Adjusted EPS and Free Cash Flow guidance:Revenue guidance narrowed to 7.5% to 8.6%; midpoint raised by 7...
Themefolio
Profiler
Peergroup
© PR Newswire
10.07.2025
LH
LISTED
NYSE
Labcorp Declares Quarterly Dividend
News Preview
BURLINGTON, N.C., July 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 11, 2025, to stockholders of record as of the...
Themefolio
Profiler
Peergroup
© PR Newswire
26.06.2025
LH
LISTED
NYSE
Labcorp to Announce Second Quarter Financial Results on July 24, 2025
News Preview
BURLINGTON, N.C., June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that...
Themefolio
Profiler
Peergroup
© PR Newswire
18.06.2025
LH
LISTED
NYSE
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care
News Preview
New offering delivers convenient, comprehensive lab testing solutions for functional medicine, integrative medicine and primary care providers
BURLINGTON, N.C., June 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp Whole Health Solutions to supp...
Themefolio
Profiler
Peergroup
© PR Newswire
30.05.2025
LH
LISTED
NYSE
Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research
News Preview
New test offerings target solid tumors and hematologic malignancies
Enhanced biopharma services support accelerated clinical trials and companion diagnostic development
BURLINGTON, N.C., May 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precis...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
LH
LISTED
NYSE
Labcorp to Webcast Its Annual Meeting of Shareholders May 15
News Preview
BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 15 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
LH
LISTED
NYSE
Labcorp Announces 2025 First Quarter Results
News Preview
Updates Full-Year Guidance
Results from Operations for first quarter 2025 versus first quarter last year:Revenue: $3.35 billion versus $3.18 billionDiluted EPS: $2.52 versus $2.69Adjusted EPS: $3.84 versus $3.68Reaffirmed Revenue and Free Cash Flow guidance, raised midpoint of adjusted EPS:Revenue guidance of 6.7% to 8.0%Adjusted EPS range of $15...
Themefolio
Profiler
Peergroup
© PR Newswire
23.04.2025
LH
LISTED
NYSE
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
News Preview
Labcorp® Plasma Detect™ now available for clinical use to assess risk of recurrence in stage III colon cancer patients
FDA-authorized liquid biopsy assay PGDx elio® plasma focus™ Dx now available to support treatment selection
BURLINGTON, N.C., April 23, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive labo...
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
LH
LISTED
NYSE
Labcorp Declares Quarterly Dividend
News Preview
BURLINGTON, N.C., April 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 11, 2025, to stockholders of record as of the clos...
Themefolio
Profiler
Peergroup
© PR Newswire
02.04.2025
LH
LISTED
NYSE
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease
News Preview
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease
BURLINGTON, N.C., April 2, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide launch of its pTau-217/Beta Amyl...
Themefolio
Profiler
Peergroup
© PR Newswire
01.04.2025
LH
LISTED
NYSE
Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide
News Preview
New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen)
BURLINGTON, N.C., April 1, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer nat...
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
LH
LISTED
NYSE
Labcorp to Announce First Quarter Financial Results on April 29, 2025
News Preview
BURLINGTON, N.C., March 31, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2025 before the market opens on Tuesday, April 29, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that...
Themefolio
Profiler
Peergroup
© PR Newswire
11.03.2025
LH
LISTED
NYSE
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
News Preview
Transaction to extend Labcorp's leadership in oncology and expand access to the company's high-quality clinical laboratory services
BURLINGTON, N.C. and MIAMI, March 11, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutic...
Themefolio
Profiler
Peergroup
© PR Newswire
24.02.2025
LH
LISTED
NYSE
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
News Preview
Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw
BURLINGTON, N.C., Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM, a circul...
Themefolio
Profiler
Peergroup
© PR Newswire
06.02.2025
LH
LISTED
NYSE
Labcorp Announces 2024 Fourth Quarter and Full Year Results
News Preview
Company Provides 2025 Guidance
Results from Continuing Operations versus last year:Revenue: Q4 of $3.33 billion vs $3.03 billion; Full year of $13.01 billion vs $12.16 billionDiluted EPS: Q4 of $1.70 vs $(1.95); Full year of $8.84 vs $4.33Adjusted EPS: Q4 of $3.45 vs $3.30; Full year of $14.57 vs $13.56Free Cash Flow: Q4 of $665.1 million vs $412...
Themefolio
Profiler
Peergroup
© PR Newswire
10.01.2025
LH
LISTED
NYSE
Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
BURLINGTON, N.C., Jan. 10, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, at 3:45 p.m. (PT)....
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2025
LH
LISTED
NYSE
LABCORP DECLARES QUARTERLY DIVIDEND
News Preview
BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 12, 2025, to stockholders of record as of the close...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2025
LH
LISTED
NYSE
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
News Preview
BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET th...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
LH
LISTED
NYSE
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians
News Preview
New test supports public health preparedness efforts and testing infrastructure amid multistate outbreak of H5 bird flu in poultry and dairy cows
BURLINGTON, N.C., Dec. 17, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the commercial availability of its new H5 bird fl...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2024
LH
LISTED
NYSE
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
News Preview
Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer Symposium
BOSTON and BURLINGTON, N.C., Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awarenes...
Themefolio
Profiler
Peergroup
© PR Newswire
26.11.2024
LH
LISTED
NYSE
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
News Preview
Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer Symposium
BOSTON and BURLINGTON, N.C., Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awarenes...
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2024
LH
LISTED
NYSE
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
News Preview
Praia Health, the consumer experience orchestration platform for health systems, is pleased to announce it has secured a strategic investment from the Labcorp Venture Fund and will collaborate with Labcorp, a global leader of innovative and comprehensive laboratory services, to streamline and personalize the patient experience for lab orders and t...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
LH
LISTED
NYSE
Labcorp Announces 2024 Third Quarter Results
News Preview
Updates Full-Year Guidance
Results from Continuing Operations for third quarter 2024 versus last year:Revenue: $3.28 billion versus $3.06 billionDiluted EPS: $2.00 versus $2.11Adjusted EPS: $3.50 versus $3.38Free Cash Flow: $162 million versus $171 millionUpdated Full-Year 2024 Guidance:Revenue range of 6.6% to 7.3%; midpoint unchangedAdjusted EP...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2024
LH
LISTED
NYSE
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
News Preview
NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor of its First To Know® Syphilis Test in professional and healthcare settings. Through Labcorp’s extens...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
LH
LISTED
NYSE
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test
News Preview
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide
BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has expanded its portfolio of sexually tr...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
LH
LISTED
NYSE
Labcorp Declares Quarterly Dividend
News Preview
BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13, 2024, to stockholders of record as of the close of busine...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2024
LH
LISTED
NYSE
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
News Preview
BURLINGTON, N.C., Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to dis...
Themefolio
Profiler
Peergroup
© PR Newswire
18.09.2024
LH
LISTED
NYSE
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience
News Preview
New solution is the first holistic program available in a digital app to help women manage the postpartum period
BOSTON, Sept. 18, 2024 /PRNewswire/ -- Ovia Health by Labcorp (Ovia) today announced the expansion of its women's health solutions to include a personalized, comprehensive Postpartum Experience – a 12-month program designed to help wom...
Themefolio
Profiler
Peergroup
© PR Newswire
17.09.2024
LH
LISTED
NYSE
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034
News Preview
BURLINGTON, N.C., Sept. 16, 2024 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) (Labcorp) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH), has priced its offering of $2,000,000,000 in senior notes (the Offering). The Offering consists of three tranches: $650,000,000 aggregate principal amount o...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
LH
LISTED
NYSE
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
News Preview
BURLINGTON, N.C., Sept. 3, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, at 3:10 p.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
02.08.2024
LH
LISTED
NYSE
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
News Preview
PGDx elio™ plasma focus Dx is the industry's first and only kitted, pan-solid tumor liquid biopsy test that enables tumor mutation profiling – all from a simple blood draw
BURLINGTON, N.C., Aug. 2, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has received De Novo...
Themefolio
Profiler
Peergroup
© PR Newswire
01.08.2024
LH
LISTED
NYSE
Labcorp Announces 2024 Second Quarter Results
News Preview
Updates Full-Year Guidance
Results from Continuing Operations for second quarter 2024 versus last year:Revenue: $3.22 billion versus $3.03 billionDiluted EPS: $2.43 versus $1.74Adjusted EPS: $3.94 versus $3.42Free Cash Flow: $432.9 million versus $58.2 millionUpdated Full-Year 2024 Guidance:Revenue range of 6.4% to 7.5%, includes Invitae impact o...
Themefolio
Profiler
Peergroup
© PR Newswire
30.07.2024
LH
LISTED
NYSE
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities
News Preview
BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Ultima Genomics to utilize its UG 100TM sequencing solution and ppmSeqTM technology to explore new whole genome sequencing (WGS) clinical appli...
Themefolio
Profiler
Peergroup
© PR Newswire
25.07.2024
LH
LISTED
NYSE
Labcorp Declares Quarterly Dividend
News Preview
BURLINGTON, N.C., July 25, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 13, 2024, to stockholders of record as of the close of busin...
Themefolio
Profiler
Peergroup
© PR Newswire
01.07.2024
LH
LISTED
NYSE
Labcorp to Announce Second Quarter Financial Results on August 1, 2024
News Preview
BURLINGTON, N.C., July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2024 before the market opens on Thursday, August 1, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discus...
Themefolio
Profiler
Peergroup
© PR Newswire
17.06.2024
LH
LISTED
NYSE
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
News Preview
Suite of digital and data solutions designed to improve clinical trial efficiency, reduce data delays and simplify investigator site workflows
BURLINGTON, N.C. , June 17, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp Global Trial Connect, a suite...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2024
LH
LISTED
NYSE
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
News Preview
Labcorp® Tissue Complete, a comprehensive genomic profiling service, now available in Geneva and Shanghai to support global clinical trials
Company expands leadership in liquid biopsy comprehensive genomic profiling for solid tumors with the integration of OmniSeq® INSIGHT circulating tumor DNA
BURLINGTON, N.C., June 3, 2024 /PRNewswire/ -- Labco...
Themefolio
Profiler
Peergroup
© PR Newswire
30.05.2024
LH
LISTED
NYSE
Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting
News Preview
Abstracts offer insights into precision oncology diagnostics for triple-negative breast cancer, liquid biopsy and machine learning for tumor profiling
BURLINGTON, N.C., May 30, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will present several abstracts at the 2024 American Society o...
Themefolio
Profiler
Peergroup
© PR Newswire
28.05.2024
LH
LISTED
NYSE
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
News Preview
BURLINGTON, N.C., May 28, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2:00 p.m. (CT)....
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2024
LH
LISTED
NYSE
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
News Preview
Labcorp is now the only lab that can detect preeclampsia risk across all pregnancy trimesters
BURLINGTON, N.C., May 15, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of its first trimester preeclampsia screening test to be performed between 11 and 14 weeks...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2024
LH
LISTED
NYSE
Labcorp to Webcast Its Annual Meeting of Shareholders
News Preview
BURLINGTON, N.C., May 8, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 14 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2024
LH
LISTED
NYSE
Invitae Receives Court Approval for Sale to Labcorp
News Preview
Acquisition advances Labcorp's specialty testing strategy in key areas such as oncology and rare diseases
Key milestone reached in Invitae's Chapter 11 process
BURLINGTON, N.C. and SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
